UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $7.90 Million Holdings in Axcelis Technologies, Inc. (NASDAQ:ACLS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 38.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,299 shares of the semiconductor company's stock after selling 47,198 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.23% of Axcelis Technologies worth $7,895,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in ACLS. Signaturefd LLC grew its stake in shares of Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company's stock valued at $30,000 after acquiring an additional 164 shares in the last quarter. Blue Trust Inc. increased its position in Axcelis Technologies by 223.8% during the 2nd quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company's stock worth $39,000 after purchasing an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new position in Axcelis Technologies in the 2nd quarter valued at approximately $39,000. Isthmus Partners LLC boosted its holdings in shares of Axcelis Technologies by 87.3% during the 2nd quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company's stock valued at $47,000 after acquiring an additional 15,507 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Axcelis Technologies during the second quarter valued at about $69,000. Institutional investors and hedge funds own 89.98% of the company's stock.

Axcelis Technologies Stock Down 0.8 %

ACLS traded down $0.61 during midday trading on Tuesday, hitting $76.49. The company had a trading volume of 615,204 shares, compared to its average volume of 633,446. The stock's 50 day moving average price is $85.48 and its 200 day moving average price is $108.04. Axcelis Technologies, Inc. has a 52 week low of $69.35 and a 52 week high of $158.61. The company has a market capitalization of $2.49 billion, a price-to-earnings ratio of 11.32, a PEG ratio of 2.31 and a beta of 1.53. The company has a quick ratio of 3.29, a current ratio of 4.45 and a debt-to-equity ratio of 0.04.

Analysts Set New Price Targets

ACLS has been the topic of several analyst reports. Needham & Company LLC reissued a "hold" rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Benchmark lowered shares of Axcelis Technologies from a "buy" rating to a "hold" rating in a report on Friday, November 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.